To view this email as a web page, click here.
February 19, 2019
 
ARRIVE, ASCEND and the Future of Aspirin
The future role of aspirin in primary prevention of CV disease is unclear—and results of recent large randomized trials point to why. More, here.
(©Shane Maritch/Shutterstock.com)
Read more
 
Hypertension Treatment: Start Strong, Please
Lisinopril 80 mg was the patient's starting dose. I saw him one year later–on the same drug, same dose, and not at target BP. There is a better way.
Read more
ADVERTISEMENT
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.